Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 1
1999 2
2001 2
2002 1
2005 1
2007 1
2009 2
2012 1
2019 1
2020 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

14 results

Results by year

Filters applied: . Clear all
Page 1
Current Therapeutic Options for the Main Monogenic Autoinflammatory Diseases and PFAPA Syndrome: Evidence-Based Approach and Proposal of a Practical Guide.
Soriano A, Soriano M, Espinosa G, Manna R, Emmi G, Cantarini L, Hernández-Rodríguez J. Soriano A, et al. Front Immunol. 2020 Jun 3;11:865. doi: 10.3389/fimmu.2020.00865. eCollection 2020. Front Immunol. 2020. PMID: 32655539 Free PMC article. Review.
This review analyzes the treatment of the most frequent monogenic autoinflammatory diseases, namely, familial Mediterranean fever, tumor necrosis factor receptor-associated periodic fever syndrome, hyperimmunoglobulin D syndrome/mevalonate kinase deficiency, and cryopyrin-associa …
This review analyzes the treatment of the most frequent monogenic autoinflammatory diseases, namely, familial Mediterranean fever, tumor nec …
Successful treatment of complex aphthosis with colchicine and dapsone.
Lynde CB, Bruce AJ, Rogers RS 3rd. Lynde CB, et al. Arch Dermatol. 2009 Mar;145(3):273-6. doi: 10.1001/archdermatol.2008.591. Arch Dermatol. 2009. PMID: 19289756
All the patients were treated according to a therapeutic ladder, starting with colchicine and adding dapsone to treatment of patients who did not have a substantial response (>75% improvement) to colchicine or who discontinued colchicine use because …
All the patients were treated according to a therapeutic ladder, starting with colchicine and adding dapsone to treatment of p …
Selecting topical and systemic agents for recurrent aphthous stomatitis.
Eisen D, Lynch DP. Eisen D, et al. Cutis. 2001 Sep;68(3):201-6. Cutis. 2001. PMID: 11579786 Review.
Recurrent aphthous stomatitis (RAS) is one of the most common oral diseases worldwide. ...Patients with frequent exacerbations or those with a severe form of RAS that is unresponsive to topical treatments often require systemic agents to control their disease. These …
Recurrent aphthous stomatitis (RAS) is one of the most common oral diseases worldwide. ...Patients with frequent exacerbations …
Practical aspects of management of recurrent aphthous stomatitis.
Altenburg A, Abdel-Naser MB, Seeber H, Abdallah M, Zouboulis CC. Altenburg A, et al. J Eur Acad Dermatol Venereol. 2007 Sep;21(8):1019-26. doi: 10.1111/j.1468-3083.2007.02393.x. J Eur Acad Dermatol Venereol. 2007. PMID: 17714120 Review.
Treatment of recurrent aphthous stomatitis (RAS) remains, to date, empirical and non-specific. ...In more severe cases, topical therapies are again very useful in decreasing the healing time but fail to decrease the interval between attacks. Systemic immunomodulator …
Treatment of recurrent aphthous stomatitis (RAS) remains, to date, empirical and non-specific. ...In more severe cases, topica …
Value of colchicine as treatment for recurrent oral ulcers: A systematic review.
Cabras M, Carrozzo M, Gambino A, Broccoletti R, Sciascia S, Baldovino S, Arduino PG. Cabras M, et al. J Oral Pathol Med. 2020 Sep;49(8):731-740. doi: 10.1111/jop.13020. Epub 2020 May 12. J Oral Pathol Med. 2020. PMID: 32281694 Free article.
BACKGROUND: In oral medicine, colchicine is a therapeutic alternative for idiopathic recurrent aphthous stomatitis (RAS), Behcet disease (BD), periodic fever, aphthous stomatitis, pharyngitis and cervical adenitis (PFAPA) syndrome, and mouth and …
BACKGROUND: In oral medicine, colchicine is a therapeutic alternative for idiopathic recurrent aphthous stomatitis (RAS …
Behçet's disease and complex aphthosis.
Ghate JV, Jorizzo JL. Ghate JV, et al. J Am Acad Dermatol. 1999 Jan;40(1):1-18; quiz 19-20. doi: 10.1016/s0190-9622(99)70523-2. J Am Acad Dermatol. 1999. PMID: 9922007 Review.
Treatment is based on the severity of systemic involvement and includes topical therapies as well as colchicine, dapsone, thalidomide, and immunosuppressive agents....
Treatment is based on the severity of systemic involvement and includes topical therapies as well as colchicine, dapsone, thal …
Complex aphthosis: a large case series with evaluation algorithm and therapeutic ladder from topicals to thalidomide.
Letsinger JA, McCarty MA, Jorizzo JL. Letsinger JA, et al. J Am Acad Dermatol. 2005 Mar;52(3 Pt 1):500-8. doi: 10.1016/j.jaad.2004.10.863. J Am Acad Dermatol. 2005. PMID: 15761429 Review.
BACKGROUND: Recurrent aphthous stomatitis is a common problem with 20% to 50% of the population having experienced simple aphthous lesions (ie, canker sores). ...METHODS: Eighty-one patients were referred to the Wake Forest University School of Medicine, Depa …
BACKGROUND: Recurrent aphthous stomatitis is a common problem with 20% to 50% of the population having experienced simple a …
[Dermato-mucosal manifestations of Behçet's disease].
Francès C. Francès C. Ann Med Interne (Paris). 1999 Nov;150(7):535-41. Ann Med Interne (Paris). 1999. PMID: 10637669 Review. French.
When there is no systemic lesions requiring oral corticosteroids or immunosuppressive therapy, colchicine, aspirine, or dapsone may be prescribed. Thalidomide is sometimes required if aphthosis is refractory to other treatments despite its neurotixic and teratogenic …
When there is no systemic lesions requiring oral corticosteroids or immunosuppressive therapy, colchicine, aspirine, or dapsone …
Oral aphthosis: management gaps and recent advances.
Liang MW, Neoh CY. Liang MW, et al. Ann Acad Med Singap. 2012 Oct;41(10):463-70. Ann Acad Med Singap. 2012. PMID: 23138144 Free article.
Two hundred and thirteen patients were identified using the search terms 'oral ulcers', 'aphthous ulcers', 'oral aphthosis', and 'Behcet's disease'. Patients with Behcet's disease without oral ulcers and other diagnoses such as pemphigus vulgaris, lichen planus and herpes …
Two hundred and thirteen patients were identified using the search terms 'oral ulcers', 'aphthous ulcers', 'oral aphthosis', and 'Beh …
Severe recurrent aphthous stomatitis treated with adalimumab: A case report in a teenage patient.
de Perosanz-Lobo D, Latour I, Ortega-Quijano D, Fernández-Guarino M, Torrelo A. de Perosanz-Lobo D, et al. Pediatr Dermatol. 2019 Nov;36(6):986-987. doi: 10.1111/pde.14003. Epub 2019 Oct 6. Pediatr Dermatol. 2019. PMID: 31588588
Recurrent aphthous stomatitis (RAS) is a chronic disorder of unknown etiology characterized by recurring ulcers involving the oral mucosa in patients with no other manifestations. ...In its major form, RAS can be a severe and disabling disorder due to pain and scarr …
Recurrent aphthous stomatitis (RAS) is a chronic disorder of unknown etiology characterized by recurring ulcers involving the …
14 results